The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated•Originally published 19 March 2026•Updated 19 March 2026•

1 min read

FiscalNote Holdings Reports Narrower Q4 Loss, Misses Revenue Estimates

Key Facts

1Marker Therapeutics reported a quarterly loss of $0.04 per share.

3 months ago

Version History

7 additional sources confirmed this story

Version 13 months ago

What changed: Updated the report to include FiscalNote Holdings' Q4 financial results, highlighting the year-over-year loss improvement and the revenue miss.

FiscalNote Holdings (NOTE) reported a fourth-quarter loss of $0.66 per share, slightly outperforming the Zacks Consensus Estimate of a $0.67 loss. This result represents a significant year-over-year improvement compared to the $1.2 per share loss recorded in the same period last year. Despite the narrower-than-expected loss, the company's revenue for the quarter fell short of analyst projections. The financial results highlight the company's progress in reducing its net losses while facing challenges in top-line growth. Investors are evaluating the mixed performance as the company navigates its path toward profitability. The stock's reaction reflects the balance between the earnings beat and the revenue miss in the current market environment.